INS and Hyperglycemia: • Higher incidence of new-onset diabetes and hyperglycemia in COVID patients.• Increased risk of new-onset diabetes by about 40% following SARS-CoV-2 infection.• Pancreatic islet cell stress, reduced insulin expression, and β-cell apoptosis, has been observed.